Morning Market Movers

By: via Benzinga
Amicus Therapeutics (NASDAQ: FOLD) climbed 28.26% to $2.36 after the company reported positive 12- and 24-month data from Phase 3 Fabry ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.